
News|Articles|December 3, 2025
AI-Driven Prognostics: Predicting Patient Outcomes from Histopathology with Objective, Scalable Intelligence
Author(s)LabVantage
AI-powered prognostics used in histopathology can reveal complex patterns in tissue and cells that exceed human vision capabilities. We present how the incorporation of these models into laboratory workflows creates more objective, reproducible, and scalable processes. This affords greater diagnostic accuracy, faster turnaround times, and patient care that best fits their needs. By handling variability and subjectivity in traditional methods, this approach supports more confident prognoses and better clinical outcomes.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Shaping the Future of Microbial Development: From Gene to GMP
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Women in STEM: Inspiration from Innovators in Pharma
4
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
5